Clinical Trial

Exercise Therapy for Isotretinoin Users

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 2, 2025 (before its estimated February 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
Isotretinoin (13-cis retinoic acid) is a retinoic acid that is a derivative of vitamin A. Isotretinoin has been used effectively alone in acne treatment for 35 years. However, it has many side effects. Among the musculoskeletal side effects of this treatment, acute sacroileitis is a common condition. In this clinical picture, recovery may last for a few months after discontinuation of isotretinoin treatment. However, it may become permanent in some cases. According to our current knowledge, there is no study in the literature that prescribes exercise therapy for this patient group. This study, planned to investigate the effects of stretching and sacroiliac mobilization exercises on musculoskeletal pain and quality of life, which are among the side effects of isotretinoin treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-24
Trial Details
NCT Number NCT07196787
Lead Sponsor Uşak University
Conditions Isotretinoin, Isotretinoin Adverse Reaction
Enrollment 160 participants
Start Date 2025-09-30
Primary Completion 2026-02-06 (estimated)
Study Completion 2026-03-26 (estimated)
Updated on ClinicalTrials.gov 2025-12-02